Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Betterleap›
Analysis
AddedFeb 15, 2024
UpdatedJul 17, 2026
Betterleap

Betterleap

Seed

Betterleap provides an AI healthcare recruiting agent that sources, engages, and rediscovers candidates for healthcare organizations.

HQ
San Francisco, CA, US
Founded
2020
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Website

Contents

  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths
  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths

Product Overview

Betterleap’s flagship product is an AI healthcare recruiting agent that lets talent teams describe a role in plain language and receive a qualified, licensure-verified candidate pipeline in seconds. The agent searches more than 35 million healthcare professional profiles and checks licensing data from more than 25 state board partnerships, reducing manual screening and compliance risk.

The platform supports two operating modes: a fully agentic mode that runs end-to-end sourcing and outreach, and a supervised mode that gives recruiters control over filters and candidate selection. It also offers ATS rediscovery, bi-directional ATS sync with systems such as Oracle, UKG, iCIMS, Workday, and Greenhouse, and autonomous email sequencing with personalized follow-ups and engagement analytics.

Market Outlook

Healthcare recruiting is under sustained pressure from clinical workforce shortages, high turnover, and rising temporary staffing costs, creating strong demand for automation that can source credentialed candidates faster. Betterleap targets this need with an AI agent that combines a large healthcare profile database with verified licensing data and autonomous outreach.

The broader AI recruiting software market is expected to keep growing as enterprise HR teams adopt generative AI for sourcing, engagement, and analytics. Betterleap’s positioning at the intersection of healthcare staffing and agentic AI gives it a clear expansion path beyond tech recruiting into regulated, high-volume clinical hiring segments.

Competitive Advantages

Betterleap differentiates itself through healthcare-specific depth, combining more than 35 million verified healthcare profiles with live licensing data from over 25 state board partnerships. This reduces the compliance burden for hospital systems and staffing agencies that must confirm candidate credentials before outreach.

The platform’s agentic workflow automates not only candidate search but also personalized outreach and follow-up, while its ATS rediscovery capability refreshes stale internal candidate databases. A founding team with prior startup and Airbnb product experience, plus backing from a16z and Peak State Ventures, gives Betterleap strong go-to-market and technical momentum in a crowded recruiting-tech market.